Form 4: QuidelOrtho Interim CEO Michael Iskra Reports Stock Transactions

Michael Iskra, Interim CEO of QuidelOrtho, reports the release of restricted stock units and subsequent tax withholding, affecting his beneficial ownership of company stock.

Summary

• On March 28, 2024, Michael Iskra, Interim CEO of QuidelOrtho Corp, reported transactions involving the company's common stock.
• 4,925 restricted stock units were released, resulting in the acquisition of an equal number of common shares at $0.00.
• Iskra also disposed of 1,773 shares to cover tax withholding obligations at a price of $47.94 per share.
• Following these transactions, Iskra beneficially owns 14,350 shares of QuidelOrtho common stock.
• The reported transactions also include the purchase of 291 shares pursuant to the Issuer's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.

Positives

• The reporting person purchased 291 shares pursuant to the Issuer's Employee Stock Purchase Plan.

Negatives

• 1,773 shares were disposed of to cover tax obligations related to the release of restricted stock units at $47.94 per share.

Future Outlook

The remaining 9,850 restricted stock units will vest in equal installments on March 28, 2025 and March 28, 2026.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the actions of company executives regarding their holdings of company stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in the number of shares held by a key executive.

Key Dates